In late January, the Pharmaceutical Research and Manufacturers of America (PhRMA) launched a national, multi-year advertising and public affairs campaign on behalf of America’s biopharmaceutical companies, including AMAG Pharmaceuticals. The GOBOLDLY campaign will highlight the important contribution of our industry and employees to advance science that helps tackle serious health conditions facing patients in the United States and around the world.
The campaign will encompass novel advertising across TV, print, digital, radio, and other platforms outside the home. A new website, GoBoldly.com, allows visitors to access the new advertisements and more information about the focus of the campaign. PhRMA has also redesigned its Innovation.org website to provide in-depth information about new developments in biopharmaceutical innovation. Three areas of focus the industry will continue to address and convene dialogue around are the New Era of Medicine, the Value Collaborative, and Public Health to engage patients, researchers, caregivers, and policymakers.
To watch the new GOBOLDLY TV spot, visit https://youtu.be/VA–ZEJLoH8.
Learn more about the campaign at GoBoldly.com and Innovation.org.
